US patent office grants Charpentier CRISPR...The US Patent Office has granted the Charpentier/Doudna key CRISPR patent, which was previously involved in an interference proceeding. more ➔
European Parliament greenlights Horizon Eu...As a first result of the trilogue on the €100m+ Horizon Europe programme, MEPs backed the backbone of the EU’s future research and innovation programme. more ➔
Biotechpharma UAB expanding productionLituanian CDMO Biotechpharma UAB has invested €50m in order to expand its production capacity to 5000 litres. more ➔
Kiadis Pharma NV to acquire CytoSen Therap...Kiadis Pharma NV has entered a definitive agreement to acquire US-based CytoSen Therapeutics, Inc. in order to create a leader in cell-based cancer immunotherapy. more ➔
Treating diabetes by mimicking gut bacteri...Researchers at University of Glasgow report that modulation of a specific GPCR results in health benefits normally mediated by a healthy gut microbiome. more ➔
Immunic lists at NasdaqChronic inflammatory disease company Immunic Therapeutics starts Nasdaq-trade following merger with Vital Therapies. more ➔
Preventing virus infections in newborns Scientists from Belgium and the US have found a way to prevent the devasting consequences of herpes infections for newborn babies. more ➔
Evotec and Indivumed join forces in CRCEvotec SE and Indivumed GmbH have entered into a drug R&D collaboration aimed at developing first-in-class colorectal cancer treatments. more ➔
Theranexus colloborates with AI expert Dyl...Lyon-based neurology specialist Theranexus SA has launched a new bioinformatics partnership with systems biology data analysts from Dyliss (Dynamics, Logics and Inference for biological Systems and … more ➔
uniQure Receives FDA Fast Track Designatio...Following the FDA granted AMT-130 fast track designation, uniQure NV announced it will start Phase I/II testing of the Huntingtons Disease gene therapy in Q2/2019. more ➔
